This guidance note sets out an overview of the rationale and the requirements of transfer pricing and the arm’s length principle.

It discusses the typical models used in life sciences and touches upon the transfer pricing documentation requirements.

This content is restricted to members. To view this content please register or login below to view this content.

Register to receive up-to-date information and advice on tax developments within your industry.